Results 81 to 90 of about 18,601 (258)

Cardiovascular Drug Use and Risk of Actinic Keratosis: A Case-Control Study

open access: yesDermatology and Therapy, 2020
Introduction Actinic keratosis (AK) is a precancerous skin lesion. Currently, many experts treat actinic keratosis as squamous cell carcinoma in situ. It is well established that exposure of the skin to ultraviolet radiation is a major risk factor for ...
Olga Warszawik-Hendzel   +5 more
doaj   +1 more source

Biomolecular Changes Upon Ablative Laser Therapy of the Skin: A Scoping Review

open access: yesInternational Journal of Dermatology, EarlyView.
(Fractional) ablative laser therapy results in a wound healing response characterized by an inflammatory phase, dermal matrix degradation, and remodeling, collagenesis and elastogenesis. This is characterized by an increase in metalloproteinases, collagen type I, III, VII, and tropoelastin.
Marie‐Eline Pauline Henriette Debeuf   +4 more
wiley   +1 more source

Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream

open access: yesJournal of Translational Medicine, 2007
Background The objective of this study was to identify the molecular processes responsible for the anti-lesional activity of imiquimod in subjects with actinic keratosis using global gene expression profiling.
Raghavan Shalini   +9 more
doaj   +1 more source

Swiss clinical practice guidelines on field cancerization of the skin. [PDF]

open access: yes, 2014
Actinic keratosis (AK) affects millions of people worldwide, and its prevalence continues to increase. AK lesions are caused by chronic ultraviolet radiation exposure, and the presence of two or more AK lesions along with photodamage should raise the ...
Anliker, M.   +12 more
core   +2 more sources

KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis – Results from a three‐armed RCT

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In this RCT, KOH 5% demonstrated superior clinical success to diclofenac 3% and placebo at the end of treatment in patients with mild‐to‐moderate actinic keratosis and comparable long‐term efficacy to diclofenac. Its fast onset of efficacy and favourable tolerability make KOH a valuable treatment option in early‐stage actinic keratosis treatment ...
U. Reinhold   +18 more
wiley   +1 more source

An Unusual Case of Perineural Infiltration and Orbital Invasion of Squamous Cell Carcinoma Associated with Actinic Keratosis

open access: yesCase Reports in Ophthalmological Medicine, 2020
Actinic keratosis is considered a precancerous lesion, constituting a precursor to squamous cell carcinoma (SCC) formation. Perineural invasion has been observed in patients with cutaneous carcinoma due to local subcutaneous tissue destruction and ...
Edgard Farah   +6 more
doaj   +1 more source

Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma. [PDF]

open access: yes, 2016
Because many patients with unresectable basal cell carcinoma (BCC) are aged ≥65 years, this study explores the efficacy and safety of vismodegib in these patients with locally advanced (la) or metastatic (m) basal cell carcinoma (BCC) in the ERIVANCE BCC
Arron, Sarah   +8 more
core   +2 more sources

AI‐assisted basal cell carcinoma diagnosis with LC‐OCT: A multicentric retrospective study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Real‐time AI assistance significantly improves dermatologists' performance in diagnosing basal cell carcinoma with LC‐OCT, outperforming traditional imaging methods. AI‐assisted novices reached expert‐level performance, bridging a 2‐year expertise gap, thus supporting a broader clinical adoption of non‐invasive technologies, reducing the need for ...
Sébastien Fischman   +64 more
wiley   +1 more source

Identification of differentially expressed genes in actinic keratosis samples treated with ingenol mebutate gel.

open access: yesPLoS ONE, 2020
Actinic keratosis is a common skin disease that may progress to invasive squamous cell carcinoma if left untreated. Ingenol mebutate has demonstrated efficacy in field treatment of actinic keratosis.
Sonia Segura   +7 more
doaj   +1 more source

A novel light source with tuneable uniformity of light distribution for artificial daylight photodynamic therapy [PDF]

open access: yes, 2018
This project was supported by the University of St. Andrews through the Science and Technology Facilities Council (STFC) Impact Accelerator Award (IAA) and by the Laser Research and Therapy Fund (registered charity SC030850). P O’M is funded by Medi-lase
Brown, C. Tom A.   +5 more
core   +3 more sources

Home - About - Disclaimer - Privacy